Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -4.97% is 29% above its 5-year average of -6.98%, near the high end of its 5-year range (-8.87%–-4.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.00% above its 12-month average of -7.20%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -4.97%.
RETURN ON INVESTED CAPITAL (ROIC)
-4.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-7.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-7.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-6.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-7.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+31.00%
CURRENT VS 3Y AVG
+30.85%
CURRENT VS 5Y AVG
+28.90%
CURRENT VS 10Y AVG
+29.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 652 covered companies
CURRENT VS SECTOR MEDIAN
+85.23%
vs the sector median at left
OrthoPediatrics Corp.
Market Cap
$583.78M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-7.20%
3Y Avg
-7.18%
5Y Avg
-6.98%
Market Cap
$591.58M
Return on Invested Capital (ROIC)
-11.80%
TTM Avg
-7.26%
3Y Avg
-5.22%
5Y Avg
9.70%
Market Cap
$574.60M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$568.81M
Return on Invested Capital (ROIC)
-25.42%
TTM Avg
25.46%
3Y Avg
-12.61%
5Y Avg
-20.42%
Market Cap
$566.03M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
-1.63%
3Y Avg
-31.88%
5Y Avg
-39.02%
Market Cap
$603.31M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
Market Cap
$561.45M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-66.45%
3Y Avg
-57.50%
5Y Avg
-60.06%
Market Cap
$606.87M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$560.00M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $583.78M | -4.97% | -7.20% | -7.18% | -6.98% |
| Fulgent Genetics, Inc. (FLGT)vs › | $591.58M | -11.80% | -7.26% | -5.22% | 9.70% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $574.60M | -45.62% | -46.61% | -61.97% | -71.18% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $568.81M | -25.42% | 25.46% | -12.61% | -20.42% |
| CorMedix Inc. (CRMD)vs › | $566.03M | 27.87% | -1.63% | -31.88% | -39.02% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $603.31M | 58.60% | 17.42% | -47.16% | -23.48% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $561.45M | -56.99% | -66.45% | -57.50% | -60.06% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $606.87M | -47.96% | -47.20% | -41.20% | -37.18% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.18M | -43.41% | -39.91% | -39.91% | -39.91% |
ROIC
-5.0%
ROE
-11.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -4.97% |
| 2026-03-31 | -6.41% |
| 2025-12-31 | -6.92% |
| 2025-09-30 | -8.81% |
| 2025-06-30 | -8.87% |
| 2025-03-31 | -8.38% |
| 2024-12-31 | -7.97% |
| 2024-09-30 | -6.38% |
| 2024-06-30 | -7.15% |
| 2024-03-31 | -7.12% |
| 2023-12-31 | -6.73% |
| 2023-09-30 | -7.02% |
| 2023-06-30 | -6.61% |
| 2023-03-31 | -6.13% |
| 2022-12-31 | -5.49% |
| 2022-09-30 | -4.74% |
| 2022-06-30 | -6.45% |
| 2022-03-31 | -6.91% |
| 2021-12-31 | -6.18% |
| 2021-09-30 | -8.74% |
| 2021-06-30 | -8.67% |
| 2021-03-31 | -9.76% |
| 2020-12-31 | -8.85% |
| 2020-09-30 | -6.04% |
| 2020-06-30 | -5.29% |
| 2020-03-31 | -6.76% |
| 2019-12-31 | -5.36% |
| 2019-09-30 | -5.76% |
| 2019-06-30 | -5.41% |
| 2019-03-31 | -7.77% |
| 2018-12-31 | -9.27% |
| 2018-09-30 | -18.00% |
| 2018-06-30 | -17.01% |
| 2018-03-31 | -14.29% |
| 2017-12-31 | -8.87% |
| 2017-09-30 | -17.94% |
| 2017-06-30 | -21.69% |
| 2017-03-31 | -21.86% |
| 2016-12-31 | -26.03% |
